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Objective: To summarize our experiences in the treatment of labor induction in placenta previa using
uterine artery embolization.
Case report: We retrospectively analyzed the clinical data of seven patients with placenta previa who
underwent antepartum uterine artery embolization before vaginal delivery. After antepartum emboli-
zation, ﬁve patients with placenta previa had successful vaginal deliveries and two cases of placenta
previa with accreta underwent emergency hysterectomy. Some complications were reported in this
experience. The follow-up study showed that most patients resumed their normal menstruation and
some of them were able to conceive.
Conclusion: For the management of placenta previa, uterine artery embolization is a minimally invasive
technique that helps to avoid cesarean section. The impact on menstruation and fertility is yet to be seen.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
The placenta begins to develop after blastocyst implantation
into the endometrium. In some cases, the placenta is implanted in
the lower uterine segment close to or even covering the internal
cervix os, or invades through the endometrium and myometrium,
which causes placenta previa and placenta accreta, respectively [1],
whichmay lead to hemorrhagewhen vaginal delivery is attempted.
Arterial embolization was ﬁrst described by Brown et al [2] to
control postpartum bleeding. We present our experiences with
induction of labor for placenta previa with the help of antepartum
uterine artery embolization (UAE).
Material and methods
A retrospective analysis of UAE performed for the management
of abnormal placental implantation was carried out from
November 2007 to December 2012. Abnormal placental implanta-
tion was preoperatively diagnosed using ultrasonography (USG),s and Gynecology, The First
umber 6 Shuang Yong Road,
bstetrics & Gynecology. Publishedmagnetic resonance imaging (MRI) or both. According to the
diagnosis, all the patients were divided into two groups: placenta
previa (PP) and placenta previa with accrete (PPþPA). In the PP
group, all patients were diagnosed with total placenta previa using
USG, within gestational age 22e29 weeks. These patients chose the
vaginal route to terminate their pregnancy because of fetal death
and serious fetal malformations. In the PAþPP group, gestational
age was within 21e22 weeks, and was diagnosed as total placenta
previa with placenta accreta with the aid of USG and MRI; patients
desired to terminate the pregnancy because of persistent vaginal
bleeding. All patients gave informed consent for their management.
Ethacridine lactate (Rivanol) amniotic induction was performed
in ﬁve patients with placenta previa and in two patients with
placenta previa with accreta soon after they received antepartum
embolization. The contractile effect of ethacradine lactate is
mediated through the activation of mast cells in the myometrium
that releasemediators, such as prostaglandin F2a, prostaglandin E2,
prostacyclin, and thromboxane A2 [3].
This procedure was performed using a 5-Fr Cobra catheter
(TERUMO, HangZhou, China) via a femoral artery approach.
Embolization of both uterine arteries was carried out preferentially
using pledgets of absorbable gelatin sponge (Elatine Sponge,
NanJing, China), as well as Fibre Steel Coil (Cordis Corporation). For
the PP and PPþPA groups, ethacridine lactate amniotic inductionby Elsevier Taiwan LLC. All rights reserved.
Table 1
Outcome after uterine artery embolization: our experience.
Patient types Case no. Mode of delivery Hysterectomy (Y/N) Placenta expelled Complications Menses Subsequent pregnancy (Y/N)
Placenta previa 1 VD N SE Normal Y
2 VD N SE Normal
3 VD N SE Normal
4 VD N MRP þ UC Femoral artery thrombosis Normal Y
5 VD N SE Normal Y (abortion)
Placenta previa and accreta 6 VD Y Infection
7 CS Y Infection
CS ¼ cesarean section; MRP ¼ manual removal of placenta; N ¼ no; SE ¼ spontaneously expelled; UC ¼ uterine curettage; VD ¼ vaginal delivery; Y ¼ yes.
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group, methotrexate was injected into the uterine arteries before
blocking the vessels with gelatin sponge. We conﬁrmed all the
patient's vital signs were stable and that coagulation proﬁles were
normal before embolization.Results
All the placenta previa cases, who received antepartum embo-
lization and ethacridine lactate amniotic induction, had successful
vaginal deliveries without excessive blood loss (Cases 1e5; Table 1).
In the PPþPA group, one case of placenta accreta with previa (Case
6) also had vaginal delivery but with retained placenta. Case 7
underwent cesarean section because of uncontrolled bleeding
during labor. Eventually, Cases 6 and 7 underwent emergency
hysterectomy because of massive hemorrhage (total blood
loss > 5 L in each case): one occurred at the time of placenta
expulsion (1 month after delivery), and the other during labor.
Placenta increta and percreta were diagnosed intraoperatively and
a pathological examination on the hysterectomy specimens in both
cases was performed. In Case 7, the placenta had invaded the
bladder wall and partial cystectomy was performed, however, MRI
did not disclose this ﬁnding before surgery.
Severe complications of UAE were reported in a few cases. One
case in the PP group had femoral artery thrombosis due to long
duration of catheterization. However, after thrombectomy and
thrombolysis, the patient had a good outcome (Case 4; Table 1).
Infection was a complication in patients with retained placenta.
During subsequent clinical follow up by the obstetrician (from 3
months to 4 years), no midterm complications were reported.
During the follow-up study, we were able to contact the ﬁve
patients with placenta previa. All ﬁve reported normal postpartum
menstruation without any change in menstrual cycle and men-
strual ﬂow. Three patients conceived after their deliveries; among
them, two patients had uneventful pregnancies and one asked for
an abortion.Discussion
Medical termination of midtrimester pregnancy with placenta
previa has been reported [4]. Reviewing these articles, most termi-
nations were carried out in the early second trimester, and there are
no reports regarding third trimester termination. Pelvic arterial
embolization to control obstetric hemorrhage was reported in suc-
cession [5,6]. Therefore, in this study, we performed UAE in the pa-
tients with complete placenta previa following ethacridine lactate
amniotic induction.UAEblocks themainblood supplyof theplacenta,
hence reducing bleeding when vessels rupture during uterine con-
tractions. From theoutcome inour study,we concluded thatUAE is an
effective method to avoid cesarean section and hemorrhage in pa-
tients with placenta previa who need pregnancy termination.With regard to the two cases of placenta previa with accreta,
conservative management was unsuccessful, even though sup-
ported with adjuvant therapy, methotrexate, which acts by
inducing placental necrosis and expediting placenta involution
[7e10]. During the operation, we found that the placenta had
already invaded the uterine wall, leading to placenta percreta. The
reason for this may be the invasion of the uterinewall and posterior
bladder wall by the placenta, and perfusion from the bladder artery.
In this situation, UAE is not sufﬁcient to block the blood supply
completely to the placenta. Another possible reason may be due to
continuous vascularization after embolization. Sherer et al [8] re-
ported multiple bilateral UAE in patients with placenta previa
percreta and the successful conservative management conﬁrms
this point.
Although UAE is effective for control of hemorrhage caused by
placenta previa, a serious complication has been reported, namely,
femoral artery thrombosis. We consider that the skilled technique
described in the present study might be a measure to reduce this
complication [11]. Infectionwas reported in our study, which can be
controlled by prophylactic broad-spectrum antibiotic therapy.
With regard to the effect of embolization on themenstrual cycle,
we showed that patients resumed their normal menstruation after
1e3 months, which was similar to the study of Descargues et al
[12]. UAE provokes obliteration and reduction in uterine perfusion,
thus, it is possible that uterine hypovascularization can induce
some pregnancy complications later. In our study, there was the
limitation of subsequent pregnancy after UAE, but it does not
conﬁrm that it was because of uterine hypovascularization that
there was limitation of subsequent pregnancy. Randomized trials
would be desirable to quell any future controversy [13].
In conclusion, the advantages of UAE in the management of
placenta previa have been established. Our study indicates that a
woman who undergoes arterial embolization can resume her
normal menstruation and reproduction. As long as long-term ef-
fects are concerned, more cases need to be studied.Conﬂicts of interest
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